Medical News

Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung C...
NEJM

In patients with resectable NSCLC, neoadjuvant nivolumab plus chemotherapy resulted in significantly longer event-...

27 May 2022

Efficacy and Safety of Maintenance Immune Checkpoint Inhibit...
BMC Cancer

ICIs with or without pemetrexed can be used as maintenance therapy after first-line ICIs plus 4–6 cycles of...

25 May 2022

When to Add Anti-angiogenesis Drugs to EGFR-mutated Metastat...
BMC Cancer

First-line combination EGFR-TKI plus anti-angiogenesis therapy improves PFS in patients with stage IV EGFR-mutant...

24 May 2022

Differentiated Thyroid Carcinoma in the Elderly: Influence o...
Endocrine

Although age is a conditioning factor for OS, very old patients do not have a greater risk of developing structural...

20 May 2022

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

 
Email this page

Key Trials

Efficacy and Safety of Low-Dose BCG vs Standard-Dose BCG in NMIBC

Although low-dose BCG had higher recurrence rate than standard-dose BCG, tumor progression, cancer-specific survival, and overall survival were...

Efficacy and Safety of Pazopanib Monotherapy in Treatment-naive and cytokine-pre-treated Patients with Advanced and/or Metastatic RCC

This study investigated efficacy and safety of pazopanib monotherapy in treatment-naive and cytokine-pre-treated patients with advanced and/or...

PALETTE Trial: Efficacy and Safety of Pazopanib with Placebo for Soft-tissue Sarcoma

The PALETTE Study investigated the effect of pazopanib on progression-free survival in patients with metastatic non-adipocytic soft-tissue sarcoma...

Efficacy and Safety of Pazopanib and Sunitinib in Patients with Metastatic Renal-cell Carcinoma as First-line Treatment

The study compared the efficacy and safety of pazopanib and sunitinib in patients with metastatic renal-cell carcinoma as first-line treatment....

Patient Education

All You Need to Know About Erlotinib

Erlotinib is a indicated for Lung and Pancreatic cancer. This input describes Erlotinib administration & possible side effects.

All You Wanted to Know About Thyroid Cancer

Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding.